Business Daily from THE HINDU group of publications
Monday, November 30, 2009
ePaper | Mobile/PDA Version | Audio | Blogs

News
Features
Stocks
Foreign Exchange
Shipping
Archives
Google

Subscription

Group Sites

Update at 1540 hrs (IST)


Corporate
Suven Life gets 3 European patents for new entities

MUMBAI: Suven Life Sciences on Monday said the European Patent Office (EPO) has issued three patents to its chemical entities which are used in treating nerve disorders.

“The company gets three patents — EP1537113, EP1704154 and EP1856132 and the said are valid until 2023, and 2024, 2022, respectively,” Suven said in a filing to the Bombay Stock Exchange.

The granted claims of the patents include therapeutic agents, useful in the treatment of neurodegenerative disorders like alzheimer’s, parkinson, and schizophrenia, the filing added.

“We are very pleased by the grant of these patents to Suven by EPO for our pipeline of molecules in central nervous system arena that are being developed for cognitive disorders,” the company CEO, Mr Venkat Jasti, said.

With these new patents, Suven has a total of seven granted EPO patents on new chemical entities.

These patents are exclusive intellectual property of Suven and are achieved through internal discovery research efforts, it added. — PTI

Prev: Probe team questions Kaiga employees
Next: NTPC to acquire 3 more coal mines in Indonesia


Business Line | NUS Index |



Related Topics
Alliances & Joint Ventures
Announcements
Auditing
Awards & Honours
Bonus Announcements
Company Law
Corporate Bonds
Corporate Disputes
Corporate Governance
Courts/Legal Issues
Diversification
Environment
Human Resources
Interview
IPOs
IPR
Management
Mergers & Acquisitions
New Projects
Open Offers
Outlook
Outsourcing
Overseas Borrowings
Overseas Investments
People
Performance
Preferential Allotments
Private Placement
Regulatory Bodies & Rulings
Research & Development
Restructuring
Rights Issue
Sick Units
Society & Development
Standards & Benchmarks
Taxation
Trade & Labour Unions



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright copy; 2009, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line